Open AccessThe evaluation of efficacy and tolerability of gemcitabine vs. capecitabine therapy in the second-line setting for metastatic pancreatic cancer patients with poor performance status
Author(s) -
Abdullah Sakin,
Süleyman Şahin,
Muhammed Mustafa Atçı,
Cumhur Demir,
Nurgül Yaşar,
Çağlayan Geredeli,
Şener Cihan
Publication year - 2019
Publication title -
journal of oncological sciences
Language(s) - English
Resource type - Journals
ISSN - 2452-3364
DOI - 10.1016/j.jons.2019.08.003
Subject(s) - gemcitabine , capecitabine , medicine , tolerability , oncology , pancreatic cancer , performance status , deoxycytidine , metastatic breast cancer , gastroenterology , chemotherapy , cancer , breast cancer , adverse effect , colorectal cancer
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom